Weight ceilings for better sleep

Weight ceilings for better sleep
reference
ekholm B, Spulber S, Adler M. A randomized controlled study on weighted chain ceilings for insomnia in psychiatric diseases. J Clin Sleep Med . 2020; 16 (9): 1567-1577.
Study goal
The aim of this study is to evaluate weight covers to improve sleep in people with a variety of psychiatric diseases.
draft
A randomized, controlled, blinded study in the province of Stockholm, Sweden
participant
The study participants included 120 patients in whom insomnia and one of several psychiatric disorders were diagnosed: severe depressive disorder (38 %), bipolar disorder (40 %), generalized anxiety disorder (11 %) or attention deficit hyperactivity disorder (11 %). There was no effort to concentrate on 1 gender; However, 68 % of the participants were women. The average age was 40 years with a range of 18 to 77 years. The average duration of insomnia was 20.2 years (SD 15.0). The majority of the patients were treated with medication and the researchers pointed them out not to change their medication during the study. The intake of medication includes: hypnotics (37 %), sedative (33 %), lithium (20 %), anticonvulsant (14 %), antipsychotics (23 %), antidepressants (53 %) and stimulants (9 %).
Intervention
Half of the participants were randomized of the condition with weighted ceiling, which provided a metal chain ceiling, which had a 8 kg (17.6 lb). When the participants initially tried the ceiling in the clinic and found them too heavy, they received a 6 kg ceiling instead. The control ceiling consisted of a plastic chain of the same size and shape as the metal, which resulted in a total weight of 1.535 kg (3.4 lb). One patient retired early and reported on an increase in fear with the weight ceiling. The researchers evaluated the severity of insomnia after 4 weeks. At this point, the study was opened for the following 12 months, whereby the participants either continued with the weight ceiling or switched to it if they were previously in the control group. They had the opportunity to choose from 4 blankets (2 chain ceilings with 6 or 8 kg or 2 ball ceilings with 6.5 or 7 kg). The majority (112 people) continued the study throughout the study, and the 7 that signed up were included in the end analysis.
study parameters evaluated
The primary endpoint was sleep disorders, which were evaluated on the basis of Insomnia Severity Index (ISI), an established instrument for self -assessment. The ISI has 7 items that are added up and interpreted as ≤7 (means no insomnia), 8–14 (means subliminal insomnia), 15–21 (medium -heavy insomnia) and ≥22 (severe insomnia). Secondary measures focused on daily symptoms and activity levels. This included actigraphy, the fatigue symptom of inventory and the hospital anxiety and depression scale.
important knowledge
The researchers assessed the participants to the reaction and remission of their symptoms according to the ISI score. The authors defined response as a decrease in the ISI scor by 50 % or more compared to the initial value and remission than ISI ≤7. In the first assessment after 4 weeks of application, 59.4 % of the Blanket Group had addressed 59.4 % (compared to 5.4 % of the control group) and 42.2 % were in remission (compared to 3.6 % of the control group). The therapeutic effect increased over the 12-month sequel, with 92 % of all first participants speaking and 78 % in remission. Objective measurements with actigraphy showed no significant effects on the sleep parameters, although the participants subjectively reported improved sleeping. The improvement in insomnia was 26 times higher when using a weighted blanket than with the control ceiling.
deep pressure also increases oxytocin. Oxytocin promotes relaxation, security and sleep.
The daily function improved significantly among those who used the weighted ceilings. Subjectively, the fatigue symptom of inventory. Objectively speaking, as was recorded by the actigraph, there was a general increase in daily activity, and the highlight of the activity was later.
Further analyzes compared Responder (an ISI acceptance of> 50 %) with non-responders (<50 % ISI acceptance). The responders showed a significant improvement in the subjectively reported sleep maintenance and a decrease in vigilance after falling asleep in the actigraphy. The daily activity increased in both groups; However, the temporal delay in top activity was only significant for responders. The participants who used the weight ceilings had a significant decrease in depression and anxiety symptoms.
practice implications
insomnia with comorbid psychiatric disorders is a common illness that occurs in primary care and specialist clinics. An estimated 10 % to 30 % of adults suffer from insomnia. These disorders have enormous individual costs in the form of a lower quality of life, limited daily function and personal expenses. The average costs for the treatment of insomnia are between $ 200 and $ 1,200 a year, and employees with insomnia generally lose 11.3 working days per year. The social costs of insomnia are estimated at $ 63.2 billion a year.
The pharmaceutical management available for insomnia is anything but ideal. The latest retrospective studies have shown an increased risk of Alzheimer's disease and other types of cognitive decay that are associated with the long-term use of zolpidem, benzodiazepines, antipsychotics and antidepressants. In 2017, the American Academy of Sleep Medicine (a section of the American Medical Association) found that the evidence of the use of hypnotics is "weak". 4 and continued in other publications that cognitive behavioral therapy in insomnia should be the therapy of the first choice in insomnia and should only be used if CBT-I has failed, or in connection with CBT- I in severe or acute cases. Unfortunately, the availability of CBT-I practitioners is not sufficient to treat the large number of people who suffer from insomnia.
behavioral and other treatments for insomnia and psychiatric disorders that have no side effects are ideal. In this study, 1 patient reported that he felt more anxious when using the weight ceiling. In particular, no other side effects were reported.
weight ceilings exert a uniform pressure on the whole body, either with metal chains or glass beads that are sewn between 2 fabric layers. In the public media, it is generally recommended that they correspond to 8 % to 10 % of the body weight of the person or less. There are several proposed mechanisms for their effect on insomnia. First, it is assumed that they act similarly to massages by simulating touches. We know that people sleep better when they feel socially safe and touch can be part of it. The deep pressure can stimulate the parasympathetic effect of the nervous system, while at the same time the sympathetic activation is regulated. Deep pressure also increases oxytocin. Oxytocin promotes relaxation, security and sleep.
The big question is how universal the improvement of sleep is by using a weight ceiling. This is not yet known because only a few studies have been carried out so far. Several small studies were carried out to deal with the use of weight ceilings by certain population groups. A study of children with autism showed that sleep did not improve. Children with attention deficit hyperactivity disorder had an improvement in insomnia with the weight ceiling, and adults with chronic insomnia who were otherwise healthy improved. A recently published overview article, which includes 8 studies, came to the conclusion that although there are indications of the use of weight ceilings in the treatment of anxiety states that are insufficient.
The question is for the time being: Can we recommend it to a broad spectrum of people, some of whom also have comorbid diseases of different types? There are other considerations here. On the one hand, the use of a weight ceiling is an intervention without registered or known side effects. However, it is generally known that persistent insomnia contributes to many other health conditions - from high blood pressure to anxiety and depression. Insomnia also contributes to lower living income and social costs. The price of a weighted ceiling is quite low and it is a treatment that is well received by the patient. Therefore, we can recommend using weight ceilings for patients with insomnia at the moment while we keep an eye on the emerging literature.
- bhaskar s, hemavathy d, prasad S. prevalence of chronic insomnia in adult patients and their correlation with medical comorbidities. J Family Med Prime Care . 2016; 5 (4): 780-784.
- Kessler R, Berglund PA, Coulouvrat C, et al. Insomnia and the performance of US workers: results of the America Insomnia Survey. sleep . 2011; 34 (9): 1161-1167.
- Lee J, Jun Sj, Choi J, Shin a, Lee Yj. Use of sedative hypnotics and the risk of Alzheimer's dementia: a retrospective cohort study. plus one . 2018; 13 (9): E0204413.
- Sateia MJ, Buysse DJ, Krystal ad, Neubauer DN, Hald Jl. Clinical practice guideline for the pharmacological treatment of chronic insomnia in adults: a clinical practice guideline of the American Academy of Sleep Medicine. J Clin Sleep Med . 2017; 13 (2): 307-349.
- uvänas-Moberg K, Arn I, Magnusson D. The psychobiology of emotion: the role of the oxytocinergic system. int. J. Behav. Med . 2005; 12 (2): 59-65.
- Eron K., Kohnert L., Watters A., Logan C., Weiser-Rose M., Mehler PS. Use of weighted ceilings: a systematic review. am J occu Ther . 2020; 74 (2): 7402205010P1-7402205014.